Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D). Some...

Read More

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term relationship between bariatric surgery (BS; weight loss surgery) and major adverse cardiovascular events (MACE) in patients with obesity, diabetes, and hypertension (high blood pressure; BP). The study showed that a sustained decrease in MACE occurrence was associated with BS in...

Read More

Evaluating the effect of whole grain consumption in blood sugar control of patients with diabetes.

Evaluating the effect of whole grain consumption in blood sugar control of patients with diabetes.

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effect of whole grain consumption in glycaemic (blood sugar) control of patients with diabetes. The data showed that whole grain consumption was beneficial for the control of blood glucose levels in these patients. Some background Diabetes is a condition in which patients have high blood sugar (glucose) levels...

Read More

Can fenofibrate therapy reduce the need for retinal laser treatment in patients with diabetic eye disease?

Can fenofibrate therapy reduce the need for retinal laser treatment in patients with diabetic eye disease?

Posted by on Apr 29, 2022 in Diabetes mellitus | 0 comments

In a nutshell This review evaluated the effect of prolonged fenofibrate (Tricor) treatment on the need for retinal laser treatment for diabetic eye disease in patients with type 2 diabetes (T2D). The data showed a reduced need for retinal laser treatment in these patients compared to placebo. Some background Diabetic eye disease refers to eye...

Read More

Do patients with diabetes have a different antibody response to COVID-19 vaccines compared to healthy individuals?

Do patients with diabetes have a different antibody response to COVID-19 vaccines compared to healthy individuals?

Posted by on Mar 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the antibody response and side effects associated with COVID-19 vaccines administration in patients with type 1 (T1D) and type 2 diabetes (T2D), people without diabetes. The data showed similar immune responses in patients with and without diabetes after the second COVID-19 vaccine,...

Read More

Can high-frequency spinal cord stimulation provide relief to patients with painful diabetic nerve disease?

Can high-frequency spinal cord stimulation provide relief to patients with painful diabetic nerve disease?

Posted by on Mar 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term impact of 10-kHz spinal cord stimulation (SCS) in patients with painful diabetic neuropathy (PDN; nerve disease) and refractory symptoms. The data supported the use of 10-kHz SCS for important, durable pain relief over 12 months in these patients. Some background Diabetic sensorimotor peripheral...

Read More

Comparing chiglitazar and sitagliptin effectiveness on glucose variations, insulin resistance and inflammation levels in patients with type 2 diabetes.

Comparing chiglitazar and sitagliptin effectiveness on glucose variations, insulin resistance and inflammation levels in patients with type 2 diabetes.

Posted by on Feb 13, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness of chiglitazar (Bilessglu) and sitagliptin (Januvia) on glycemic (blood glucose) variations, insulin resistance, and inflammation levels in patients with type 2 diabetes (T2D). The data showed that chiglitazar treatment was more effective at improving insulin resistance and inflammation compared...

Read More

Can physical activity affect glucose levels variations in patients with diabetes?

Can physical activity affect glucose levels variations in patients with diabetes?

Posted by on Feb 13, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effect of physical activity interventions on glycemic variability (GV; glucose levels variations) in patients with diabetes. The data showed that physical activity was associated with significantly reduced GV in these patients. Some background Physical activity has been shown to reduce hemoglobin A1c (the...

Read More

How beneficial is sodium-glucose co-transporter 2 inhibitor treatment for patients with type 2 diabetes mellitus and heart failure?

How beneficial is sodium-glucose co-transporter 2 inhibitor treatment for patients with type 2 diabetes mellitus and heart failure?

Posted by on Jan 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed the long-term use of sodium-glucose co-transporter 2 inhibitors (SGLT-2i) on the risk of mortality and hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) and heart failure (HF). The authors concluded that long-term use of SGLT-2 inhibitors can help to reduce mortality risk and HHF in...

Read More

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Posted by on Dec 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review assessed the risk of hypoglycemia (dangerously low blood glucose) with the addition of sodium-glucose co-transporter 2 (SGLT-2) inhibitors to sulfonylureas in patients with type 2 diabetes (T2D). The authors concluded that this combination was associated with an increased risk of hypoglycemia. Some background...

Read More

Can anti-diabetic drug use affect fracture risk in patients with type 2 diabetes?

Can anti-diabetic drug use affect fracture risk in patients with type 2 diabetes?

Posted by on Dec 19, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety of anti-diabetic drugs in the risk of fractures based on available data from clinical trials. The data showed differences in associations between the use of anti-diabetic drugs and fracture risk. Some background Patients with type 2 diabetes (T2D) are more prone to bone fragility (increased bone...

Read More